Physician

Charles H Campbell, M.D.

According to 2025 Medicare claims, Charles Campbell, M.D. (NPI: 1154395705) practices ophthalmology in the Corpus Christi, TX market, with the plurality of this provider's patient population coming from Nueces, TX. This provider's primary affiliated billing organization is SOUTH TEXAS RETINA CONSULTANTS, LLP (NPI: 1548217433; TIN: 742784568) and primary practice location at 78413-2953.

Campbell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 543 traditional Medicare patients, billed 15,559 HCPCS/CPT codes, and received $954,498 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 1,491 prescription claims across 358 beneficiaries totaling $1,692,346 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 2 records totaling $237. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $989,210 and ending at $954,498. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $198,985 to $1,692,346. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,100	10,279	$989,210
2016	1,115	9,246	$923,489
2017	1,097	10,125	$864,269
2018	614	4,043	$436,762
2019	243	1,002	$135,637
2020	684	4,195	$437,774
2021	463	2,194	$194,588
2022	422	3,315	$392,998
2023	593	8,335	$755,423
2024	543	15,559	$954,498

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	512	2,046	$198,985
2016	398	1,829	$183,468
2017	383	1,911	$218,273
2018	279	1,305	$166,396
2019	130	522	$82,170
2020	128	397	$65,481
2021	176	575	$200,583
2022	132	375	$144,733
2023	225	685	$778,936
2024	358	1,491	$1,692,346

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92235	Exam of retinal blood vessels using a special camera after injection of a dye	298	416	$112
67028	Injection of drug into eye	219	773	$83
92014	Established patient complete exam of visual system	294	409	$81
J7999	Compounded drug, not otherwise classified	144	384	$73
92134	Imaging of retina	491	1,094	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eylea	Aflibercept	466	13,167	$1,037,007
Vabysmo	Faricimab-Svoa	126	3,633	$339,361
Eylea Hd	Aflibercept	67	2,063	$205,468
Ozurdex	Dexamethasone	28	2,090	$40,737
Prednisolone Acetate	Prednisolone Acetate	93	4,534	$5,371

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$237	Harrow Eye, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles H. Campbell, M.D.?

Tedicare shows public-source Medicare data for Charles H. Campbell, M.D. (NPI 1154395705), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles H. Campbell, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles H. Campbell, M.D.?

Charles H. Campbell, M.D. is linked to SOUTH TEXAS RETINA CONSULTANTS, LLP (billing NPI 1548217433) in the available physician profile data.

Does Charles H. Campbell, M.D. have Open Payments data?

Charles H. Campbell, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.